Pricing Log in Create free account
Friday 6 November 2026 Export CRSP’s income statement to Excel — free account

CRISPR Therapeutics AG

CRSP Healthcare Biotechnology

CRISPR Therapeutics AG’s revenue for fiscal 2025 (year ended December 2025) was $3.5 million, down 90.6% from fiscal 2024.

Revenue
+1,325.1%
EPS
+1.55%
Free cash flow
−6.36%

Quarter to September 2026, against a year earlier

49.92 1.36 +2.80%
Market cap
$4.7B
P/E
0.0×
Fwd P/E
−11.8×
Dividend yield
—
F-score
2/9
Altman Z
7.04
Beneish M
n/a
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

CRISPR Therapeutics AG (CRSP) Current ratio

Alert me on Current ratio

CRISPR Therapeutics AG's current ratio at the end of the quarter to 30 September 2026 was 16.2×, up 2.9× from fiscal 2025 (13.3×). Over the past ten years it has ranged from 13.3× (fiscal 2025) to 22.1× (fiscal 2024) — the current reading is the lowest in ten years. That is above the Biotechnology industry median of 5.0× and above the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 13.3× (39.66%)
FY2024 22.1× 25.82%
FY2023 17.5× 14.63%
FY2022 15.3× (24.12%)
FY2021 20.2× 10.73%
FY2020 18.2× 5.31%
FY2019 17.3× 2.88%
FY2018 16.8× (1.80%)
FY2017 17.1× 17.60%
FY2016 14.6× (5.76%)

Quarterly newest first

Period Current ratio Change
Sep 2026 16.2× (9.17%)
Jun 2026 17.8× (0.66%)
Mar 2026 18.0× 34.91%
Dec 2025 13.3× (17.89%)
38 more quarters

Against its own ten years

Low 13.3× High 22.1×
Ten-year median 17.1×
Current reading's percentile 9

Current ratio against peers

Company Current ratio
MANE Veradermics Incorporated compare 70.5×
DNTH Dianthus Therapeutics, Inc. compare 30.0×
CRSP CRISPR Therapeutics AG 16.2×
COGT Cogent Biosciences, Inc. compare 13.6×
EWTX Edgewise Therapeutics, Inc. compare 12.3×
ERAS Erasca, Inc. compare 8.3×
DFTX Definium Therapeutics, Inc. compare 6.9×
LEGN Legend Biotech Corporation Sponsored ADR compare 3.0×
TVTX Travere Therapeutics, Inc. compare 3.0×
Biotechnology industry median 5.0×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on CRSP